Rhythm Pharmaceuticals Inc (RYTM) earnings · rev $189.8M
These earnings events as JSON? API free 100/dayRhythm Pharmaceuticals Inc (RYTM) is a biotechnology company listed on NASDAQ.
This RYTM earnings page is the cached print — revenue, income, and the latest exhibit — not a live call transcript.
Latest reported RYTM revenue for 2025-12-31 was $189.8M. Net income was -$196.5M. Revenue was up 45.8% from 2024-12-31 to 2025-12-31. RYTM currently screens at market cap $6.49B.
When the next RYTM 8-K Item 2.02 lands, this page should move. Until then the SEC archive is the source.
The change that matters: Revenue was up 45.8% from 2024-12-31 to 2025-12-31. An earnings headline that ignores that move is noise.
Not investment advice. Full RYTM research stays on the stock page; the tape stays on the quote page.
RYTM earnings FAQ
What are RYTM's latest revenue and net income?
Latest cached Rhythm Pharmaceuticals Inc (RYTM) revenue for Dec 31, 2025 was $189.8M. Net income was -$196.5M. Statements: https://lician.com/financials/rytm
What is RYTM's latest diluted EPS?
Latest cached Rhythm Pharmaceuticals Inc (RYTM) diluted EPS for Dec 31, 2025 was -$3.11.
What period does the latest RYTM earnings print cover?
The latest cached Rhythm Pharmaceuticals Inc (RYTM) earnings print covers Dec 31, 2025. The prior cached period on this page is Dec 31, 2024.
How did RYTM revenue change from the prior cached period?
Cached Rhythm Pharmaceuticals Inc (RYTM) revenue was up 45.8% from $130.1M (Dec 31, 2024) to $189.8M (Dec 31, 2025). Statements: https://lician.com/financials/rytm
Where are RYTM earnings listed?
Cached earnings facts for Rhythm Pharmaceuticals Inc (RYTM) are listed at https://lician.com/earnings/rytm. Statements: https://lician.com/financials/rytm
Not investment advice.